CIPLA.NS vs. DRREDDY.NS
Compare and contrast key facts about Cipla Limited (CIPLA.NS) and Dr. Reddy's Laboratories Limited (DRREDDY.NS).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CIPLA.NS or DRREDDY.NS.
Key characteristics
| CIPLA.NS | DRREDDY.NS | |
|---|---|---|
| YTD Return | 12.54% | 1.22% |
| 1Y Return | 54.17% | 31.05% |
| 3Y Return (Ann) | 16.87% | 4.87% |
| 5Y Return (Ann) | 22.12% | 17.72% |
| 10Y Return (Ann) | 14.60% | 10.28% |
| Sharpe Ratio | 1.98 | 1.01 |
| Daily Std Dev | 25.27% | 20.19% |
| Max Drawdown | -86.45% | -64.82% |
| Current Drawdown | -6.53% | -8.82% |
Fundamentals
| CIPLA.NS | DRREDDY.NS | |
|---|---|---|
| Market Cap | ₹1.08T | ₹978.48B |
| EPS | ₹45.93 | ₹334.54 |
| PE Ratio | 29.17 | 17.56 |
| Revenue (TTM) | ₹251.16B | ₹279.16B |
| Gross Profit (TTM) | ₹145.01B | ₹113.84B |
| EBITDA (TTM) | ₹61.30B | ₹81.05B |
Correlation
The correlation between CIPLA.NS and DRREDDY.NS is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
CIPLA.NS vs. DRREDDY.NS - Performance Comparison
In the year-to-date period, CIPLA.NS achieves a 12.54% return, which is significantly higher than DRREDDY.NS's 1.22% return. Over the past 10 years, CIPLA.NS has outperformed DRREDDY.NS with an annualized return of 14.60%, while DRREDDY.NS has yielded a comparatively lower 10.28% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CIPLA.NS vs. DRREDDY.NS - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Cipla Limited (CIPLA.NS) and Dr. Reddy's Laboratories Limited (DRREDDY.NS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CIPLA.NS vs. DRREDDY.NS - Dividend Comparison
CIPLA.NS's dividend yield for the trailing twelve months is around 0.60%, less than DRREDDY.NS's 0.68% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CIPLA.NS Cipla Limited | 0.60% | 0.68% | 0.46% | 0.53% | 0.12% | 0.63% | 0.58% | 0.33% | 0.35% | 0.31% | 0.32% | 0.50% |
DRREDDY.NS Dr. Reddy's Laboratories Limited | 0.68% | 0.69% | 0.71% | 0.51% | 0.48% | 0.70% | 0.76% | 0.83% | 0.65% | 0.64% | 0.56% | 0.59% |
Drawdowns
CIPLA.NS vs. DRREDDY.NS - Drawdown Comparison
The maximum CIPLA.NS drawdown since its inception was -86.45%, which is greater than DRREDDY.NS's maximum drawdown of -64.82%. Use the drawdown chart below to compare losses from any high point for CIPLA.NS and DRREDDY.NS. For additional features, visit the drawdowns tool.
Volatility
CIPLA.NS vs. DRREDDY.NS - Volatility Comparison
Cipla Limited (CIPLA.NS) has a higher volatility of 10.40% compared to Dr. Reddy's Laboratories Limited (DRREDDY.NS) at 7.54%. This indicates that CIPLA.NS's price experiences larger fluctuations and is considered to be riskier than DRREDDY.NS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
CIPLA.NS vs. DRREDDY.NS - Financials Comparison
This section allows you to compare key financial metrics between Cipla Limited and Dr. Reddy's Laboratories Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities